Event Type
Disclosure
Mandatory
Variant
8-K
Submission of Matters to a Vote of Security Holders. On January 22, 2026, Century Therapeutics, Inc. (the “Company”) held a special meeting of stockholders (the
Other Events. Also on January 22, 2026, the Company received of a letter from the Nasdaq Stock Market LLC advising the Company that it has regained compliance w